Does Rallies show Form 4 insider transactions for GRAL?

Yes. Rallies tracks GRAL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is GRAL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GRAL. It does not provide personalized investment advice.

GRAL (GRAIL, Inc. Common Stock) Stock Analysis - Insider Trades

GRAIL, Inc. Common Stock (GRAL) is a publicly traded Healthcare sector company. As of May 21, 2026, GRAL trades at $65.50 with a market cap of $2.61B and a P/E ratio of -6.29. GRAL moved +8.81% today. Year to date, GRAL is -31.04%; over the trailing twelve months it is +67.93%. Its 52-week range spans $12.33 to $118.84. Analyst consensus is buy with an average price target of $67.04. Rallies surfaces GRAL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GRAL stock inside the company?

Recent GRAL insider activity includes Freidin Aaron sold 45.81K, RAGUSA ROBERT P sold 123.50K, Ofman Joshua J. sold 61.66K, Freidin Aaron sold 2.41K, and Freidin Aaron sold 85. Rallies tracks insider transaction dates, shares, prices, and estimated values.

GRAL Key Metrics

Key financial metrics for GRAL
Metric	Value
Price	$65.50
Market Cap	$2.61B
P/E Ratio	-6.29
EPS	$-10.30
Dividend Yield	0.00%
52-Week High	$118.84
52-Week Low	$12.33
Volume	51
Avg Volume	0
Revenue (TTM)	$156.12M
Net Income	$-395.32M
Gross Margin	0.00%

Recent GRAL Insider Trades

Freidin Aaron sold 45.81K (~$2.29M) on Apr 8, 2026.
RAGUSA ROBERT P sold 123.50K (~$6.16M) on Apr 8, 2026.
Ofman Joshua J. sold 61.66K (~$3.08M) on Apr 8, 2026.
Freidin Aaron sold 2.41K (~$115.37K) on Mar 9, 2026.
Freidin Aaron sold 85 (~$3.97K) on Mar 9, 2026.

Latest GRAL News

GRAIL to Unveil 174,000-Patient Galleri Trial Data at 2026 ASCO Meeting — Apr 21, 2026
GRAIL Integrates Galleri Test into Epic EHR for 450 Health Systems — Apr 7, 2026
Grail Shares Halve After Trial Miss, Partners with Superpower for Galleri Rollout — Apr 1, 2026
GRAIL to Install Josh Ofman as CEO on June 1, Founder Ragusa Retires — Mar 12, 2026
Grail Inc. Price Targets Slashed to $80–$82 After Study Misses Endpoint — Feb 27, 2026

GRAL Analyst Consensus

7 analysts cover GRAL: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $67.04.

Common questions about GRAL

Who is trading GRAL stock inside the company?: Recent GRAL insider activity includes Freidin Aaron sold 45.81K, RAGUSA ROBERT P sold 123.50K, Ofman Joshua J. sold 61.66K, Freidin Aaron sold 2.41K, and Freidin Aaron sold 85. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for GRAL?: Yes. Rallies tracks GRAL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GRAL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GRAL. It does not provide personalized investment advice.